Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway
about
Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner.Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies.Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells.Galectins as Molecular Targets for Therapeutic Intervention.AP-1 confers resistance to anti-cancer therapy by activating XIAP.
P2860
Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Galectin-1 knockdown improves ...... e Raf-1/AP-1 signaling pathway
@ast
Galectin-1 knockdown improves ...... e Raf-1/AP-1 signaling pathway
@en
type
label
Galectin-1 knockdown improves ...... e Raf-1/AP-1 signaling pathway
@ast
Galectin-1 knockdown improves ...... e Raf-1/AP-1 signaling pathway
@en
prefLabel
Galectin-1 knockdown improves ...... e Raf-1/AP-1 signaling pathway
@ast
Galectin-1 knockdown improves ...... e Raf-1/AP-1 signaling pathway
@en
P2093
P2860
P356
P1433
P1476
Galectin-1 knockdown improves ...... e Raf-1/AP-1 signaling pathway
@en
P2093
P2860
P304
25097-25106
P356
10.18632/ONCOTARGET.15341
P407
P577
2017-02-15T00:00:00Z